A significant advance in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial tumor suppressor protein is frequently disabled in several types of cancer, causing https://bookmarkwuzz.com/story21955178/vhh-fragments-reactivate-tumor-suppressor-p53-new-potential-pathway-for-cancer-therapy